Free Trial

Lexeo Therapeutics (LXEO) SEC Filings & 10K Form

Lexeo Therapeutics logo
$4.62 +0.70 (+17.68%)
As of 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Lexeo Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2025
4:44 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:46 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:48 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
5:06 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:58 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:17 PM
Lexeo Therapeutics (Filer)
Form S-8 POS
03/24/2025
6:52 AM
Lexeo Therapeutics (Filer)
Form 424B5
03/24/2025
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:03 AM
Lexeo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
6:04 AM
Lexeo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
4:08 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:10 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
11:03 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
9:24 AM
Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
Form SCHEDULE 13G
02/12/2025
8:35 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
01/22/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:35 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:55 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:59 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
12/19/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
7:19 AM
Lexeo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/12/2024
4:00 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:18 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
11/26/2024
4:00 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:49 PM
Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G/A
11/14/2024
11:32 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/14/2024
11:23 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:31 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:33 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:34 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The next market Nvidia is positioned to dominate … (Ad)

Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.

To see a live demonstration with one of these robots, simply click here.
11/13/2024
6:31 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/13/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
10/30/2024
5:15 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:17 AM
Lexeo Therapeutics (Filer)
Form 424B3
10/15/2024
12:45 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:32 PM
Lexeo Therapeutics (Filer)
Form 424B3
09/11/2024
4:17 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
5:34 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:11 AM
Lexeo Therapeutics (Filer)
Form 424B3
08/09/2024
8:43 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
08/05/2024
11:54 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
07/15/2024
6:55 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:59 AM
Lexeo Therapeutics (Filer)
Form 424B3
07/12/2024
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
5:20 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:26 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
6:04 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/28/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
6:36 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/27/2024
4:01 PM
Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:01 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:02 PM
DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:04 PM
Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:05 PM
COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
8:04 AM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:04 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
4:14 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:07 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:09 AM
Lexeo Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LXEO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners